Camelot Portfolios’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $341K | Sell |
3,297
-47
| -1% | -$4.2K | 0.24% | 140 |
|
|
2026
Q1 | $240K | Sell |
3,344
-132
| -4% | -$10.2K | 0.18% | 158 |
|
|
2025
Q4 | $276K | Sell |
3,476
-1,920
| -36% | -$151K | 0.17% | 146 |
|
|
2025
Q3 | $407K | Sell |
5,396
-2,026
| -27% | -$139K | 0.24% | 117 |
|
|
2025
Q2 | $512K | Sell |
7,422
-176
| -2% | -$11.5K | 0.31% | 110 |
|
|
2025
Q1 | $515K | Sell |
7,598
-1,343
| -15% | -$80.4K | 0.32% | 108 |
|
|
2024
Q4 | $401K | Sell |
8,941
-210
| -2% | -$11.8K | 0.43% | 77 |
|
|
2024
Q3 | $575K | Sell |
9,151
-2,115
| -19% | -$123K | 0.57% | 59 |
|
|
2024
Q2 | $665K | Buy |
11,266
+2,949
| +35% | +$184K | 0.38% | 77 |
|
|
2024
Q1 | $663K | Sell |
8,317
-3,493
| -30% | -$267K | 0.65% | 54 |
|
|
2023
Q4 | $932K | Buy |
11,810
+1,056
| +10% | +$75.2K | 0.55% | 58 |
|
|
2023
Q3 | $751K | Sell |
10,754
-4,017
| -27% | -$285K | 0.72% | 46 |
|
|
2023
Q2 | $1.02M | Buy |
14,771
+1,805
| +14% | +$128K | 0.64% | 44 |
|
|
2023
Q1 | $963K | Buy |
12,966
+1,083
| +9% | +$90.8K | 0.67% | 44 |
|
|
2022
Q4 | $1.11M | Sell |
11,883
-1,503
| -11% | -$145K | 0.82% | 38 |
|
|
2022
Q3 | $1.28M | Sell |
13,386
-3,207
| -19% | -$317K | 1.2% | 25 |
|
|
2022
Q2 | $1.54M | Sell |
16,593
-2,089
| -11% | -$204K | 0.92% | 27 |
|
|
2022
Q1 | $1.89M | Sell |
18,682
-6,180
| -25% | -$649K | 0.94% | 23 |
|
|
2021
Q4 | $2.56M | Sell |
24,862
-5,365
| -18% | -$496K | 1.03% | 18 |
|
|
2021
Q3 | $2.56M | Sell |
30,227
-2,054
| -6% | -$172K | 1.32% | 13 |
|
|
2021
Q2 | $2.69M | Buy |
32,281
+587
| +2% | +$48.1K | 1.09% | 23 |
|
|
2021
Q1 | $2.38M | Buy |
31,694
+6,766
| +27% | +$493K | 0.99% | 28 |
|
|
2020
Q4 | $1.7M | Buy |
24,928
+504
| +2% | +$32.8K | 0.89% | 30 |
|
|
2020
Q3 | $1.43M | Buy |
24,424
+12,489
| +105% | +$777K | 0.89% | 31 |
|
|
2020
Q2 | $775K | Sell |
11,935
-9,767
| -45% | -$615K | 0.5% | 56 |
|
|
2020
Q1 | $1.29M | Sell |
21,702
-4,472
| -17% | -$299K | 0.72% | 35 |
|
|
2019
Q4 | $1.94M | Buy |
26,174
+1,654
| +7% | +$116K | 0.82% | 33 |
|
|
2019
Q3 | $1.55M | Sell |
24,520
-928
| -4% | -$55K | 0.73% | 35 |
|
|
2019
Q2 | $1.39M | Buy |
25,448
+6,766
| +36% | +$364K | 0.57% | 53 |
|
|
2019
Q1 | $1.01M | Buy |
18,682
+2,168
| +13% | +$134K | 0.42% | 69 |
|
|
2018
Q4 | $1.08M | Buy |
16,514
+98
| +0.6% | +$7.32K | 0.5% | 59 |
|
|
2018
Q3 | $1.29M | Buy |
16,416
+516
| +3% | +$36.9K | 0.58% | 57 |
|
|
2018
Q2 | $1.02M | Buy |
+15,900
| New | +$1.05M | 0.44% | 69 |
|
|
2017
Q4 | – | Sell |
-3,755
| Closed | -$305K | – | 190 |
|
|
2017
Q3 | $305K | Hold |
3,755
| – | – | 0.15% | 124 |
|
|
2017
Q2 | $302K | Sell |
3,755
-2,040
| -35% | -$161K | 0.15% | 128 |
|
|
2017
Q1 | $455K | Buy |
+5,795
| New | +$463K | 0.22% | 107 |
|
Other funds holding CVS
Camelot Portfolios's CVS Position: Q2 2026 in Review
Camelot Portfolios reduced its CVS Health (CVS) stake by 1.4% in Q2 2026, selling an estimated $4.2K and leaving 3,297 shares worth $341K. The position accounts for 0.24% of the portfolio, ranked #140.
Camelot Portfolios first reported a position in CVS in Q1 2017 and has held it in 36 quarters since. The position peaked at $2.69M in Q2 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Camelot Portfolios held 3,297 shares of CVS Health worth $341K as of Q2 2026.
- Camelot Portfolios sold 47 CVS Health shares in Q2 2026, an estimated $4.2K.
- CVS Health made up 0.24% of Camelot Portfolios's portfolio in Q2 2026, its #140 holding.
- Camelot Portfolios first reported a position in CVS Health in Q1 2017 and has held it in 36 quarters since.
- Camelot Portfolios's CVS Health position peaked at $2.69M in Q2 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Camelot Portfolios's 13F filing for Q2 2026, filed 17 Jul 2026.